Pulmonary Arterial Hypertension (PAH): How to Develop an Effective Risk Reduction Strategy

Описание к видео Pulmonary Arterial Hypertension (PAH): How to Develop an Effective Risk Reduction Strategy

Learn how to develop an effective clinical-risk reduction strategy to optimize treatment of patients with pulmonary arterial hypertension (PAH).

More content about PAH is available for AMA PRA Category 1 Credit(s)™
Watch the Webinar ➤ https://www.pilotforpulmonary.org/912...

View the Activity ➤ https://www.pilotforpulmonary.org/com...

Pulmonary Arterial Hypertension Playlist ➤    • Pulmonary Arterial Hypertension (PAH)...  

This video is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. Developed for physicians and advance practice providers.

Комментарии

Информация по комментариям в разработке